Therefore, in fatigue management, clinicians should highlight the importance of assessing correctly and treating anemia, whether by blood transfusions or erythropoietin (mainly epoetin alfa) as stated by international guidelines (American Society of Clinical Oncology (ASCO) and European Society for Medical Oncology (ESMO) [73, 74]). The gene discussed is EPO; the disease is anemia.